From: ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
n = 254 | BM positive (%) | p-value* | |
---|---|---|---|
Total | 254 | 107 (42) | |
Menopausal status | |||
Premenopausal | 79 | 33 (42) | 0.94 |
Postmenopausal | 175 | 74 (42) | |
Tumour size | |||
pT1 | 148 | 60 (41) | 0.77 |
pT2-4 | 103 | 46 (45) | |
Nodal status | |||
Node negative | 149 | 62 (42) | 0.88 |
Node positive | 101 | 43 (43) | |
Histology | |||
Ductal | 177 | 74 (42) | 0.12 |
Lobular | 57 | 21 (37) | |
Others | 17 | 11 (65) | |
Grading | |||
I to II | 217 | 91 (42) | 0.85 |
III | 32 | 14 (44) | |
ER status | |||
Negative | 42 | 19 (45) | 0.83 |
Positive | 208 | 88 (42) | |
PR status | |||
Negative | 69 | 26 (38) | 0.39 |
Positive | 181 | 79 (44) | |
HER2 | |||
Negative (0/+1) | 211 | 94 (45) | 0.08 |
Positive (+2/+3) | 32 | 9 (28) |